Related by context. All words. (Click for frequent words.) 71 A.2 69 B.3 67 B.2 66 See Restatement Second 66 O. Reg 65 C.1 64 -0 Contents 64 Proposed Revisions 63 Content Outline 63 Evid 63 #.#-# [005] 63 Antidumping Duties 63 Brief Description 63 Def. s 63 § #:# [001] 62 doi doi 62 Exh 62 END FOOTNOTE 62 quoting Restatement Second 62 Follow @ JohnCFierce 62 :5 62 Arch Dermatol 62 Continuous Disclosure 62 Appendix B 62 Pl. s 62 Statistical Tables 62 p.# [001] 61 CFR pt 61 LSA RS #:# [001] 61 Follow @ FierceBiotech 61 cmt 61 Va. Code § 61 Reevaluation 61 Eur J Cancer 61 annexed hereto 61 Hr'g Tr 61 NanoMarkets Releases 61 GASB Issues 61 FAR #.# 61 Biotechnol 60 punctuation omitted 60 SEC Regulation SX 60 Judgments § 60 See USSG 60 Appendix 4E 60 Analytical Methods 60 Reconciliation Tables 60 CEQA Guidelines 60 DFARS #.#-# 60 CFR § #.# [003] 60 #.# subd [004] 60 App'x 60 Ord. 60 Topics Covered Executive 60 WpHG mit dem Ziel 60 Eur Urol 60 Defs. 60 Explanatory Note 60 #:#-# [019] 60 Repl. 60 Contents Introduction 60 Coalcorp Provides Updated 60 CFR § #.# [004] 59 Stmt 59 Opp'n 59 NUREG 59 Regulations Governing 59 Ann Rheum Dis 59 Alloying 59 C.2 59 § #.# [002] 59 Microbiol 59 § #-#-# [002] 59 Supplementary Data 59 Explanatory Notes 59 -Richard Gitlen 59 .cagy veteran 59 Ozone Pollution 59 Dkt 59 CFR § #.# [008] 59 § #.#-# [004] 59 #:#-# [002] 59 § #-# [004] 59 See id 59 2d ed 59 Ark. Sup 59 § #.#.# [002] 59 § #:# [002] 59 FAR #.#-# Instructions 59 CFR #.# d 59 Recent Accounting Pronouncements 59 Sean Yuille ¤ 58 footnotes omitted 58 See ARS § 58 Docket Entry No. 58 Obstet Gynecol 58 #:#-# [014] 58 Mol Med 58 Hr'g 58 #.#-# b [001] 58 EMBO J. 58 3rd edn 58 FAR #.#-# [001] 58 Rev. Proc 58 CFR #.# [008] 58 END FOOTNOTE * 58 Environ Health Perspect 58 Resp't 58 Pl. 58 CSR #-#.# 58 Zcom Networks Announces 58 § #-#.# [003] 58 NIH Publication 58 Colo. Sess 58 Toxicol 58 Tabular 58 #:#-# Abstract Free [004] 58 MB Docket 58 Publishes Updated 58 § #-#.# [001] 58 J Pediatr 58 Regulatory Developments 58 § #a [002] 58 #:#-# Abstract Free [001] 58 What Constitutes 58 CAS #-#-# Market [001] 58 § § #-#-# [001] 58 #:#-# [027] 58 Analytical Toolbox 58 #:#-# [020] 58 Conforms 58 TCA § #-#-# [003] 58 Compl 58 LSA RS #:# [002] 58 Submission Guidelines 58 TCA § 58 doi #.# 58 Reply Br 58 doi Abstract Free 58 C.4 58 PO# [003] 58 b Vernon Supp 58 Clin Oncol 58 Section #-#-# [006] 57 #.#.#.#.#.# 57 Obviousness 57 #.#.#.# [011] 57 Segregated Facilities 57 Arch Dis Child 57 Imaging Techniques 57 CFR § #.# [006] 57 Non GAAP reconciliations 57 w xml 57 Income Tax Regs 57 Acctg 57 .W. McNichols 57 Arch Neurol 57 Maj. Op 57 Antitrust Litig 57 Suppl. 57 #A.# [001] 57 DC Code § 57 Customs Tariff Act 57 Annexures 57 Pricing Supplement 57 Practice Guideline 57 Appendices 57 #:#-# Abstract Free [008] 57 #:#-# Abstract Free [002] 57 Emerg Med 57 Torts § 57 Ratings Methodology 57 See Attachment 57 #-#.# [017] 57 Article PubMed 57 Ann Oncol 57 #:#-# [006] 57 Smooth Muscle 57 NJSA 2C :5 57 Docket Nos. 57 Thromb Haemost 57 #:#-# [018] 57 AQUARIUS PLATINUM LIMITED 57 Implementing Regulations 57 Expandable Polystyrene 57 Anders Bylund More 57 #:# -# Abstract Free [001] 57 Filing Requirements 57 #.#-# Offeror Representations 57 GRI G3 57 Molecular Structure 57 Pediatr 57 CFR #.# [006] 57 FAR #.#-# [003] 57 Significant Intercepts 57 To Length Au 57 Pract 57 Factors Impacting 57 Expert Opin 57 #:#-# Abstract Free [010] 57 BizAcumen LLC 57 Supramolecular Chemistry 57 By BHSN.com Staff 57 #:#-# Abstract Free [006] 57 Technical Specifications 57 C.# 57 constitutes discloseable transaction 57 Counterparty Criteria 57 CFR #.# b 57 Segregated Facilities Feb 57 KUNC Entertainment 57 Exs 57 Relation Between 57 Bulletin des Annonces 57 Reproduced Record RR 57 Antidumping Duty Order 57 Guidance Document 57 Prognostic Factors 57 #:#-# Abstract Free [009] 57 #:#-# Abstract Free [005] 57 Arch Pediatr Adolesc Med 57 ASX Announcements 57 Flexpoint Announces 57 Nat Genet 57 Script Insertion Vulnerability 57 #a [004] 57 USC § #a [002] 57 Audited Financials 57 Specifier 57 Solar Geophysical Activity 57 #d# [001] 57 Temporary Suspension 57 ISSN #-# 56 Appendix 5B 56 Reporting Requirements 56 USC § #u 56 Certifications Commercial 56 Offerors Commercial 56 Am J Epidemiol 56 Disclosure Requirements 56 Offerors Commercial Items 56 Stipulated 56 #.#-# [013] 56 Pub. 56 Nat Clin Pract 56 Cell Biol 56 :9 56 § § #-# [001] 56 NJSA #A 56 Supplementary Material 56 Jury Instructions 56 Tenn. R. Civ 56 Patent Reexamination 56 Free Full Text 56 Variable Annuity Sales 56 Amending Directive 56 Filing Status 56 Act Pub. L. 56 § #-#-# [004] 56 J Clin Psychiatry 56 MANAGEMENT DISCUSSION AND ANALYSIS 56 Randomized Controlled Trials 56 Disclosure Requirement 56 FR Doc 56 #S #S [001] 56 Mineral Resource Estimation 56 RoHS Compliance 56 B.5 56 Wheat Starch 56 CFR #.# [002] 56 #:#-# Abstract Free [007] 56 Supplementary Appendix 56 2nd edn 56 CFR #.#b 56 E.2 56 Endnotes 56 SABESP Announces 56 Material Fact 56 #:#-# [037] 56 ASME Boiler 56 Logistic Regression 56 Assigns LS 56 NJSA #:#-# [004] 56 Endocrinol Metab 56 Managements Discussion 56 Continuous Disclosure Policy 56 Diabet Med 56 #:#-# Abstract Free [003] 56 De Minimis 56 -Wauk 56 Suchismita Sahoo 56 S# S# [001] 56 E.1 56 Dkt. # 56 USC § #f 56 Stipulated Order 56 xsl template 56 DFARS 56 Curr Opin 56 Roxanna Maron Summerland 56 Neurobiol 56 Atmospheric Carbon Dioxide 56 alterations omitted 56 #B.# [002] 56 Newly Revised 56 Crit Care 56 Clin Trials 56 Obes Res 56 Waste Discharge 56 Rashmi r Parida 56 #.#.#R 56 R. #:#-# 56 Vernon Supp 56 AD.L Top 56 Fam. Code § 56 Revised Guidance 56 Suppl 56 Miner Res 56 Section #.# [001] 56 USFA Releases 56 XPEL Announces 56 Classification Tonnes 56 DGAP PVR Publication 56 Firefighter Fatality 56 Psychiatry #:#-# [001] 56 Prof'l 56 D.2 56 See TCA § 56 Complaint ¶ 56 Explanatory notes 56 annexure marked 56 Premerger Notification 56 FINAL REPORT 56 Eur Heart 56 Not Disclosed 56 EEO Public File 56 Arbitration Agreements 56 Certifications Commercial Items 56 J Clin Endocrinol Metab 56 FAR #.#-# Offeror Representations 56 Subsidiary Arrangements 56 Resp 56 ITEPA 56 Vertical Restraints 56 Currency Majors Technical 56 J Natl Cancer Inst 55 Reply Brief 55 J Virol 55 DOI #.# 55 Soc Sci Med 55 Okla. Stat 55 Tpull Weekly Marvel Comics 55 KRS #A.# [002] 55 CFR #.# c 55 Appendix 4E Preliminary 55 Slip Op 55 Pharmacol 55 Neurosurg 55 Id. § 55 Admissible 55 footnote omitted 55 Remote SQL Query 55 6 pgs #k 55 Funeral Notices 55 Appendix 4D 55 Urol 55 #A.# [005] 55 Clinical Outcome 55 reh'g denied 55 Def. 55 ChemPort 55 Gluten Powder 55 Psychiatry #:#-#,# Abstract Free [001] 55 Nucleic Acids Res 55 CFR § #.# [007] 55 Ownership Structure 55 Compensation Disclosure 55 Bancolombia SA Announces 55 Geriatr 55 #.# subd [006] 55 Mol Biol 55 Dan Caplinger More 55 J Cereb Blood 55 § #E 55 Going Concern Qualification 55 Fetal Pain 55 pp. #-# [004] 55 Recommended Practices 55 Air Worthiness 55 BlogPoll Ballot 55 Anti Dumping Duties 55 PremierWest Bancorp Announces 55 EEO Public 55 C.3 55 Docket Number 55 Offeror Representations 55 FOIA Requests 55 #.#-# Prohibition 55 www.x cal.com 55 Microstructure 55 #.# subds [001] 55 #:#-#,# Abstract Free 55 DOI #.#/science.# 55 IBERIABANK Corporation Reports 55 HRS § #-# [001] 55 By FilmStew Staff 55 Resubmission 55 SEBI ICDR Regulations 55 #.# 5T 55 Interval m 55 FASEB J. 55 IEC #-#-# [003] 55 3d ed 55 NYSE Amex Listing 55 italics omitted 55 Refiling 55 Pls. 55 Dkt. No. 55 Referenced 55 Ann Surg 55 #:#-# [029] 55 Employee Handbooks 55 Dent Res 55 Contained Contained 55 Statistical Methods 55 Non Exempt 55 By 3lilangels Read 55 Pa.RAP 55 Miscellaneous Provisions 55 Chemical Substances 55 J Appl 55 Nasdaq Delisting Notice 55 Fraudulent Transfer 55 Passive Component 55 Proxy Disclosure 55 Recommends Changes 55 Tonnes Ni 55 No. #R Consolidation 55 tonne Wardrop Engineering 55 Obligatoires 55 Palaeogeography Palaeoclimatology Palaeoecology 55 FERC Stats 55 Pathol 55 Inspectional Observations 55 RSMo 55 Physica 55 MARRIAGE LICENSES 55 Satellite Transponders 55 MCL #.# [002] 55 KEMET Announces 55 Dangerous Precedent 55 #.#-# b [002] 55 NASDAQ Deficiency Notice 55 J Clin Invest 55 First BanCorp Announces 55 Performance Benchmarks 55 Original Bidder Statement 55 AS NZS #:# 55 INDUSTRY DEFINITION Industry 55 Article ISI ChemPort 55 Nasdaq Deficiency Notice 55 Nephrol Dial Transplant 55 Preliminary Determination 55 INTRODUCTION I. 55 Contracts § 55 La.Code Crim.P. art 55 #G# [002] 55 Entity Relationship 55 -0 Content Outline 55 #-# Full Text 55 Psychiatry #:#-# [003] 55 Chart Presentation 55 Minn. R. Evid 55 Legal #.# 55 5TH CIR 55 J Biol 55 Significant Assay Results 55 § #-#-# [005] 55 SulphCo Announces 55 Structured Finance Transactions 55 Psychological Effects 55 See USSG § #B#.# 55 DFAR #.#-# 55 J Clin Epidemiol 55 Appendix I. 55 Joint Stipulation 55 Offerors Commercial applies 55 FOREXYARD Daily Forex 55 NAICS # [001] 55 Reaffirms FY 55 Erratum 55 Most Widely Used 55 CCH Pension Plan 55 Eligibility Requirements 55 Sentencing Guidelines Manual 55 -Genereaux 55 FCC Rcd 55 Ineffective Assistance 55 Diamyd Medical Diamyd 55 J Rheumatol 55 Cosmetic Ingredients 55 Files Amended 55 #:#-# [001] 55 Ethical Considerations 55 Measurement Specialties Announces 55 Psychiatric Diagnosis 55 Arbitration Clauses 55 Ohio Adm.Code 54 Pet'r 54 w illus 54 J Pathol 54 Subtitle B 54 Gov't Code § 54 FAR clauses 54 Administrative Procedure 54 IV.#.# 54 § #-# [001] 54 REACH SVHC 54 Disclosure Controls 54 Material Facts 54 Harsh Tactics 54 border="0"> 54 op cit 54 Provides Detailed 54 CFR #.# [001] 54 Multiscale Modeling 54 CA BUSINESS 54 Microstructural 54 Intracranial Aneurysms 54 EIN Presswire Press 54 Confirmatory Phase 54 Ala. R. Civ 54 Am J Clin 54 #:#-# [033] 54 FAR Clause #.#-# 54 ROCA Reports 54 Regulation SX 54 Ohio Adm.Code #-#-# 54 discloseable transaction 54 Contained Metal 54 David Finnis Summerland 54 #S #S [002] 54 Order Granting 54 #.#-# Convict Labor 54 alteration omitted 54 CAS #-#-# Market [002] 54 Nat Med 54 Drilling Activity 54 SPECIAL BUSINESS 54 R.# [002] 54 Practicable 54 § #-#-#.# 54 Wireless Legal Footnote 54 # et seq 54 KAR #:# 54 Complementarity 54 internal citations omitted 54 Ptf 54 Issues Shareholder 54 doi #.#/journal.pone.# 54 Antidumping Duty 54 Appendix 3B Page 54 TFT LCD Panels 54 :2 54 Docket Entry 54 .execute arbitrary SQL 54 Wyo. Stat 54 Industry Classification 54 Legal Notices 54 Favorable Ruling 54 Shipping Container 54 Section #-#-# [005] 54 #.#-# Instructions 54 Oregon Assisted Suicide 54 Finsat 54 USC #d 54 Clinical Oncology Vol 54 Study Shows Benefits 54 Br J Haematol 54 Immediate Effectiveness 54 Pooling Agreement 54 Healthnostics Announces 54 Natural Catastrophe Stress 54 Dealer Floorplan ABS 54 supra § 54 CrossRef Medline 54 Jury Instruction 54 Concession Arrangements 54 Dell'Oro Group Quarterly 54 Hollow Fiber 54 People v. Waidla 54 Saprolite mafic intrusive 54 Am J Gastroenterol 54 Woody Biomass 54 Terms Companies Mentioned 54 -Baron linguistics 54 § #-#-# b [003] 54 Substantial Shareholding 54 thereof Controls 54 Abstract Free Full Text 54 Gynecol Oncol 54 #a #a [003] 54 Medicure Announces 54 Struct 54 EPA Proposes 54 Applicability 54 J Clin Oncol 54 Third Amended Complaint 54 BioFuel Announces 54 BioElectronics Corporation Announces 54 Orissadiary correspondent 54 MakeMusic Monthly SmartMusic Subscription 54 #-#-#.# [002] 54 Lipstick Mystic Love 54 #:#-# [025] 54 #.#.# [013] 54 Eur Respir J 54 Minimization 54 Crit Rev 54 Tonnes Au 54 Psychiatr Serv 54 Proposing Release 54 #:#-# [038] 54 Packaging Materials 54 Neurosci 54 CFR § #.# [002] 54 J Clin 54 Doc. No. 54 Red Hat alert RHSA 54 -0 Key 54 Colorado Revised Statutes 54 Administrative Proceeding File 54 FINANCIAL SERVICES GUIDE 54 Balance Sheet Cash Flow 54 Mad Cow Testing 54 Compositional 54 Light Olefins 54 Sports Exerc 54 SEBI Delisting 54 Am J Pathol 54 Appendix 4D Half 54 Practical Applications 54 Dan Dzombak More 54 Subdivision Regulations 54 S1 S# [002] 54 - -Crazyhorse 54 State ex rel 54 Cashflow Report 54 Headwaters Incorporated Announces 54 RESTATEMENT SECOND OF 54 Import Restrictions 54 Mineral Resource Summary 54 Genome Res 54 #/#/EEC [002] 54 Tex. Admin 54 Annexes 54 Naturally Occurring 54 NJSA 2C :2 54 Dan Meisler Ann Arbor 54 Consequential Amendments 54 OSV Newbuild Program 54 Processor Legal Footnote 54 Tentative Subdivision 54 Topics Covered 54 Conversion Factor 54 Evidentiary Hearing 54 Kidney Int 54 Soldering Equipment 54 NOON SNAPSHOT Asia 54 Enumerated 54 KEMIRA 54 Demarc Extension 54 User Requirements 54 Restated Letter 54 Epoxy Resin 54 Liability Lawsuits 54 Assigns Outlooks 54 Short Explanation 54 Dosage Forms 54 #:#-#,# Medline 54 Preliminary Findings 54 Kara Hildreth 54 BUSINESS DESCRIPTION 54 #-#.# [016] 54 J Affect Disord 54 Listing Application 54 Half Yearly Financial 54 Ark. R. Civ 54 § #A [001] 54 Graphics Legal Footnote 54 MAG Silver Reports 54 Analyte 54 Arbitration Procedure 54 Plaintiffs Complaint 54 Physiol 54 #.#-# Contract Terms [002] 54 Non Infringement 54 #:#-#,# [003] 54 abstr 54 dkt item 54 :7 54 p.2 54 doi #.#/j.#-#.#.#.x 54 § #.# [004] 54 Pre Feasibility Progress 54 § #.#-# et seq 54 Reaffirms FY# Guidance 53 recodified 53 II Item 9A 53 CFR #.# [005] 53 #.#-# [020] 53 Tst 53 Mukasey Nomination 53 Alleged Violations 53 Sec.# [002] 53 Block Copolymer 53 Roughrider Uranium Deposit 53 Stent Placement 53 #.#-# [003] 53 I.1 53 Calgon Carbon Announces 53 Dividend Distribution 53 Mammalian Cell Culture 53 WAC #-#-# 53 Biochemical Pharmacology 53 Oncol 53 HKN NHL 53 Resolutions Adopted 53 Aero Term 53 Neurol 53 Space Shuttle Processing 53 Conductive Polymers 53 Countervailing Duties 53 #.#-# [001] 53 Fundamentally Flawed 53 NJAC #:#-#.# 53 Drill Hole Location 53 Online Drugstore 53 Joint Surg Am 53 Binding Offer 53 § #-#.# [004] 53 Appendix 53 Foreseeable 53 Stockholder Approval 53 Proposed Private Placement 53 Standards Codification ASC 53 Int J Epidemiol 53 Proposed Regulations 53 Resource Utilization 53 Hematol 53 #-#.# [014] 53 Programming Languages 53 Palladon Announces 53 hereby GRANTED 53 Scheduling Order 53 Adverse Reactions 53 Listing Rule #.#A 53 Ameris Bancorp Reports 53 Reportlinker Adds Global 53 Appendix 4C 53 Sexual Assault Cases 53 Electronic Invoice 53 Proven Mineral Reserves 53 BIOLASE Announces 53 Avcorp announces 53 Lin Fanjing linfanjing@xinhua.org 53 Satellite Radio Merger 53 J Am Soc 53 -Rejustors 53 § #.# d 53 Port Auth 53 Tristate AM 53 Review Strategic Alternatives 53 Regular Monthly Distributions 53 Increasing Importance 53 Non GAAP Measurements 53 IBTimes.com More 53 RESOURCE ESTIMATE 53 Darvon Darvocet Banned Darvocet 53 Greenhouse Gas Emission Reduction 53 Prof. Code § 53 Pending Litigation 53 Hum Mol Genet 53 #A #B [002] 53 Mandatory Arbitration 53 #.#-# [033] 53 Evaluation Tool 53 Proposed Arrangement 53 Cost Estimating 53 Travis Hoium More 53 Equine Veterinary Journal 53 Lifts FY# View 53 Restatement Third 53 Broiler Chick Placements 53 Non GAAP Measure 53 Clarification Regarding 53 Dividend Quick Facts 53 Affirmative Action Ban 53 Appraised Value 53 § #B#.# [002] 53 Psychiatry #:#-#,# Abstract Free [002] 53 Docket # 53 Antitrust Laws 53 #:#-#,# CrossRef Medline [002] 53 Restatement Second 53 Accounting Pronouncements 53 Graco Stroller Recall 53 INDEPENDENT REVIEW 53 TOP Ships Announces 53 Supply Capability 53 #.# RSMo 53 Composite Material 53 Imports Exports 53 Permissible 53 #:#-#,# CrossRef 53 Comair Pilots 53 USCS § 53 Chapter 6D 53 Nonferrous Metal 53 Ongoing Connected Transactions 53 Materiality 53 Burgl Unoccupied Conveyance Unarmed 53 ARS § 53 vol.# 53 Inferred Resource Estimate 53 Hotly Debated 53 MSc Qualified Person 53 Permit Application 53 Structural Changes 53 Undisputed Facts 53 Generic Biologics 53 Appellant App 53 Stats. 53 TZ Section 53 Flammability 53 #K#.# 53 SEP# # 53 Seasonal Pattern 53 Freshwater Wetlands 53 Further Cautionary Announcement 53 Clin Infect Dis 53 #:# -# [005] 53 SHIRE PLC 53 Multiple Dwelling 53 Proxy Proposals 53 Corn Silage 53 NRS #A.# 53 CICA Accounting Guideline 53 Individual Retirement Arrangements 53 Biol Psychiatry 53 Minn. R. Civ 53 Geochimica et Cosmochimica Acta 53 Reference Manual 53 Genetically Engineered Animals 53 mso ansi language 53 CFR Parts 53 Chp 53 Genome Sequence 53 Option Grants 53 Supplementary Prospectus 53 COMPANY CONSOLIDATED INCOME STATEMENTS 53 #/#/# Appendix 3B [003] 53 Pg. 53 Molecular Mechanism 53 CFR § § 53 Curb Illegal 53 Epidemiol 53 J Exp Med 53 Practice Direction 53 Backs FY# Forecast 53 WTC Rebuilding 53 Consensus Forecasts 53 Finalize Joint Venture 53 Hedging Relationships 53 p.8 53 Psychosom Med 53 www.californian.com 53 Freeform Sdn Bhd 53 s Opp'n 53 AFI #-# 53 STATE STREET CORPORATION 53 consequential amendments 53 Publishes Article 53 RFID Tagging 53 Bankr 53 Corporate Governance Policies 53 Gerdau Ameristeel Announces 53 Perspect 53 Related Transactions 53 #:# -# Abstract Free [002] 53 CLSI Publishes 53 INV Management Discussion 53 Assumed Name 53 DJ CBOT Corn 53 #:#-#,# [002] 53 Matt Koppenheffer More 53 http:/hugin.info/#/R/#/#.pdf [001] 53 Resale Registration Statement 53 RH DONNELLEY CORPORATION 53 Datasheet 53 La Ce Pr 53 GENERAL ELECTRIC COMPANY 53 Dkt. 53 subparagraphs 53 IRC § § 53 III.#.# 53 #-#-# [070] 53 Severability 53 Backs FY# 53 Empirical Evidence 53 Formal Agreements 53 Psychiatry #:#-# [002] 53 Industry Profile CIC# 53 DJ DGAP PVR Publication 53 Psychol Med 53 Hematological Cancers 53 Capitalised terms 53 preambular 53 ContentType 53 Radionuclides 53 Condensed Consolidated Interim 53 Biodegradable Plastics 53 Nondiscrimination 53 Chronic Lyme Disease 53 SMARTREND NEWS 53 Sodium Intake 53 ICAO Annex 53 Biol 53 See Tex. 53 Product Specifications 53 competitively procured pursuant 53 Comparative Figures 53 Bearish Trend 53 Continuations 53 Bulk Sampling Program 53 #:#-# [023] 53 Nonstandard 53 Reconstitute 53 Hereinafter 53 Permanent Impairment 53 Pa.CS § 53 § 8C 53 ISI Medline 53 eResearch Issues Initiating 53 Terminate Merger 53 SPECTRUM BRANDS 53 Reaffirms FY# Revenue 53 Explanatory 53 Equiv 53 Regulation RRO 53 http:/www.ncbi.nlm.nih.gov/pubmed/# 53 #.#A [005] 53 Abstract Full Text 53 #.# subd [003] 53 Centrifugal Pumps 53 Organizational Structure 53 Psychiatric Services #:#-#,# 53 Procedural Rules 53 Stock Option Expensing 53 Preferential Issues 53 Combustible Dust 53 Uninsured Motorists 53 § #-#-# [006] 53 Recapitalization Plan 53 internal quotations omitted 53 See IRS Publication 53 SHENGDATECH INC. AND SUBSIDIARIES 53 § #.# [006] 53 Crowflight Announces 53 Testing Methodology 53 AirIQ Announces 53 Continued Listing Requirements 53 #-# #-# [013] 53 Deba Prasad Dash 53 Mol Cell 53 Pre Cancerous 53 Obligor 53 Bijender Sharma 53 Arsenic Levels 53 # endif 53 numéro de 53 Revises Outlooks 53 Textile Exports 53 Security Bypass Vulnerability 53 al Tabari vol.# 53 Photovoltaic Cell 53 Uniform Arbitration 53 #.#-# Contract Terms [001] 53 HIRAN RATNAYAKE 53 Regulation FD Disclosure 53 Obtains Financing 53 Dimensioning 53 Silicates 53 Reprod 53 SUPPLEMENTARY INFORMATION 53 section #-#-# [003] 53 Assigns Stable Outlook 53 Unsanitary Conditions 53 Plastic Resins